Abstract
Radiomics is an emerging field that involves extraction and quantification of features from medical images. These data can be mined through computational analysis and models to identify predictive image biomarkers that characterize intra-tumoral dynamics throughout the course of treatment. This is particularly difficult in gliomas, where heterogeneity has been well established at a molecular level as well as visually in conventional imaging. Thus, acquiring clinically useful features remains difficult due to temporal variations in tumor dynamics. Identifying surrogate biomarkers through radiomics may provide a non-invasive means of characterizing biologic activities of gliomas. We present an extensive literature review of radiomics-based analysis, with a particular focus on computational modeling, machine learning, and fractal-based analysis in improving differential diagnosis and predicting clinical outcomes. Novel strategies in extracting quantitative features, segmentation methods, and their clinical applications are producing promising results. Moreover, we provide a detailed summary of the morphometric parameters that have so far been proposed as a means of quantifying imaging characteristics of gliomas. Newly emerging radiomic techniques via machine learning and fractal-based analyses holds considerable potential for improving diagnostic and prognostic accuracy of gliomas.
Key points
• Radiomic features can be mined through computational analysis to produce quantitative imaging biomarkers that characterize intra-tumoral dynamics throughout the course of treatment.
• Surrogate image biomarkers identified through radiomics could enable a non-invasive means of characterizing biologic activities of gliomas.
• With novel analytic algorithms, quantification of morphological or sub-regional tumor features to predict survival outcomes is producing promising results.
• Quantifying intra-tumoral heterogeneity may improve grading and molecular sub-classifications of gliomas.
• Computational fractal-based analysis of gliomas allows geometrical evaluation of tumor irregularities and complexity, leading to novel techniques for tumor segmentation, grading, and therapeutic monitoring.
Similar content being viewed by others
References
Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278(2):563–577. https://doi.org/10.1148/radiol.2015151169
Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, Forster K, Aerts HJ, Dekker A, Fenstermacher D, Goldgof DB, Hall LO, Lambin P, Balagurunathan Y, Gatenby RA, Gillies RJ (2012) Radiomics: the process and the challenges. Magn Reson Imaging 30(9):1234–1248. https://doi.org/10.1016/j.mri.2012.06.010
Zhou M, Chaudhury B, Hall LO, Goldgof DB, Gillies RJ, Gatenby RA (2017) Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction. J Magn Reson Imaging 46(1):115–123. https://doi.org/10.1002/jmri.25497
Gutman DA, Cooper LA, Hwang SN, Holder CA, Gao J, Aurora TD, Dunn WD Jr, Scarpace L, Mikkelsen T, Jain R, Wintermark M, Jilwan M, Raghavan P, Huang E, Clifford RJ, Mongkolwat P, Kleper V, Freymann J, Kirby J, Zinn PO, Moreno CS, Jaffe C, Colen R, Rubin DL, Saltz J, Flanders A, Brat DJ (2013) MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology 267(2):560–569. https://doi.org/10.1148/radiol.13120118
Kotrotsou A, Zinn PO, Colen RR (2016) Radiomics in brain tumors: an emerging technique for characterization of tumor environment. Magn Reson Imaging Clin N Am 24(4):719–729. https://doi.org/10.1016/j.mric.2016.06.006
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1
Bredel M, Scholtens DM, Harsh GR, Bredel C, Chandler JP, Renfrow JJ, Yadav AK, Vogel H, Scheck AC, Tibshirani R, Sikic BI (2009) A network model of a cooperative genetic landscape in brain tumors. JAMA 302(3):261–275. https://doi.org/10.1001/jama.2009.997
Sturm D, Witt H, Hovestadt V, Khuong-Quang D-A, Jones David TW, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, Kool M, Zapatka M, Becker N, Zucknick M, Hielscher T, Liu X-Y, Fontebasso Adam M, Ryzhova M, Albrecht S, Jacob K, Wolter M, Ebinger M, Schuhmann Martin U, van Meter T, Frühwald Michael C, Hauch H, Pekrun A, Radlwimmer B, Niehues T, von Komorowski G, Dürken M, Kulozik Andreas E, Madden J, Donson A, Foreman Nicholas K, Drissi R, Fouladi M, Scheurlen W, von Deimling A, Monoranu C, Roggendorf W, Herold-Mende C, Unterberg A, Kramm Christof M, Felsberg J, Hartmann C, Wiestler B, Wick W, Milde T, Witt O, Lindroth Anders M, Schwartzentruber J, Faury D, Fleming A, Zakrzewska M, Liberski Pawel P, Zakrzewski K, Hauser P, Garami M, Klekner A, Bognar L, Morrissy S, Cavalli F, Taylor Michael D, van Sluis P, Koster J, Versteeg R, Volckmann R, Mikkelsen T, Aldape K, Reifenberger G, Collins VP, Majewski J, Korshunov A, Lichter P, Plass C, Jabado N, Pfister Stefan M (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425–437. https://doi.org/10.1016/j.ccr.2012.08.024
Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8):765–773. https://doi.org/10.1056/NEJMoa0808710
Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F, El Hallani S, Boisselier B, Mokhtari K, Hoang-Xuan K, Delattre J-Y (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27(25):4150–4154. https://doi.org/10.1200/JCO.2009.21.9832
Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O’Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB (2015) Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372(26):2499–2508. https://doi.org/10.1056/NEJMoa1407279
Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Brown PD, Shaw EG, Buckner JC (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66(20):9852–9861. https://doi.org/10.1158/0008-5472.CAN-06-1796
Hegi ME, Liu L, Herman JG, Stupp R, Wick W, Weller M, Mehta MP, Gilbert MR (2008) Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26(25):4189–4199. https://doi.org/10.1200/JCO.2007.11.5964
Delfanti RL, Piccioni DE, Handwerker J, Bahrami N, Krishnan A, Karunamuni R, Hattangadi-Gluth JA, Seibert TM, Srikant A, Jones KA, Snyder VS, Dale AM, White NS, McDonald CR, Farid N (2017) Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status. J Neuro-Oncol 135(3):601–609. https://doi.org/10.1007/s11060-017-2613-7
Haas-Kogan DA, Prados MD, Tihan T, Eberhard DA, Jelluma N, Arvold ND, Baumber R, Lamborn KR, Kapadia A, Malec M, Berger MS, Stokoe D (2005) Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. JNCI: J Natl Cancer Instit 97(12):880–887. https://doi.org/10.1093/jnci/dji161
Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, Verhaak RGW, Hoadley KA, Hayes DN, Perou CM, Schmidt HK, Ding L, Wilson RK, Van Den Berg D, Shen H, Bengtsson H, Neuvial P, Cope LM, Buckley J, Herman JG, Baylin SB, Laird PW, Aldape K (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17(5):510–522. https://doi.org/10.1016/j.ccr.2010.03.017
Raab SS, Grzybicki DM, Janosky JE, Zarbo RJ, Meier FA, Jensen C, Geyer SJ (2005) Clinical impact and frequency of anatomic pathology errors in cancer diagnoses. Cancer 104(10):2205–2213. https://doi.org/10.1002/cncr.21431
Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883–892. https://doi.org/10.1056/NEJMoa1113205
Friedmann-Morvinski D (2014) Glioblastoma heterogeneity and cancer cell plasticity. Crit Rev Oncog 19(5):327–336. https://doi.org/10.1615/critrevoncog.2014011777
Inda MM, Bonavia R, Seoane J (2014) Glioblastoma multiforme: a look inside its heterogeneous nature. Cancers (Basel) 6(1):226–239. https://doi.org/10.3390/cancers6010226
Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, Cheshier SH, Napel S, Zaharchuk G, Plevritis SK (2014) Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology 273(1):168–174. https://doi.org/10.1148/radiol.14131731
Zinn PO, Mahajan B, Sathyan P, Singh SK, Majumder S, Jolesz FA, Colen RR (2011) Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One 6(10):e25451. https://doi.org/10.1371/journal.pone.0025451
Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A, Aerts HJ (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48(4):441–446. https://doi.org/10.1016/j.ejca.2011.11.036
Djuricic GJ, Radulovic M, Sopta JP, Nikitovic M, Milosevic NT (2017) Fractal and gray level cooccurrence matrix computational analysis of primary osteosarcoma magnetic resonance images predicts the chemotherapy response. Front Oncol 7:246. https://doi.org/10.3389/fonc.2017.00246
Parekh V, Jacobs MA (2016) Radiomics: a new application from established techniques. Expert Rev Precis Med Drug Dev 1(2):207–226. https://doi.org/10.1080/23808993.2016.1164013
Haralick RM, Shanmugam K, Dinstein I (1973) Textural features of image classification. IEEE Trans Syst Man Cybern 3(6):610–621. https://doi.org/10.1109/TSMC.1973.4309314
Czarnek N, Clark K, Peters KB, Mazurowski MA (2017) Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study. J Neuro-Oncol 132(1):55–62. https://doi.org/10.1007/s11060-016-2359-7
Mazurowski MA, Czarnek NM, Collins LM, Peters KB, Clark K (2016) Predicting outcomes in glioblastoma patients using computerized analysis of tumor shape - preliminary data. In: Progress in Biomedical Optics and Imaging - Proceedings of SPIE. https://doi.org/10.1117/12.2217098
Ditmer A, Zhang B, Shujaat T, Pavlina A, Luibrand N, Gaskill-Shipley M, Vagal A (2018) Diagnostic accuracy of MRI texture analysis for grading gliomas. J Neuro-Oncol 140(3):583–589. https://doi.org/10.1007/s11060-018-2984-4
Galloway MM (1975) Texture analysis using gray level run lengths. Comput Graphics Image Process 4(2):172–179. https://doi.org/10.1016/S0146-664X(75)800086
Amadasun M, King R (1989) Textural features corresponding to textural properties. IEEE Trans Syst Man Cybern 19(5):1264–1274. https://doi.org/10.1109/21.44046
Ojala T, Pietikäinen M, Mäenpää T (2002) Multiresolution gray-scale and rotation invariant texture classification with local binary patterns, vol 24. vol 7 %. J IEEE Trans Pattern Anal Mach. Intell. IEEE Computer Society. https://doi.org/10.1109/tpami.2002.1017623
Ambrosini RD, Wang P, O'Dell WG (2010) Computer-aided detection of metastatic brain tumors using automated three-dimensional template matching. J Magn Reson Imaging 31(1):85–93. https://doi.org/10.1002/jmri.22009
Lowe DG (1999) Object recognition from local scale-invariant features. In: Proceedings of the Seventh IEEE International Conference on Computer Vision, 20–27 Sept. 1999. pp 1150–1157 vol.1152. https://doi.org/10.1109/ICCV.1999.790410
Dalal N, Triggs B (2005) Histograms of oriented gradients for human detection. In: 2005 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (CVPR'05), 20–25 June 2005. vol. 881. pp 886–893. https://doi.org/10.1109/CVPR.2005.177
Mandelbrot BB, Freeman WH, Company (1983) The fractal geometry of nature. Henry Holt and Company
Di Ieva A, Grizzi F, Jelinek H, Pellionisz AJ, Losa GA (2013) Fractals in the neurosciences, part I: general principles and basic neurosciences. Neuroscientist 20(4):403–417. https://doi.org/10.1177/1073858413513927
Di Ieva A, Esteban FJ, Grizzi F, Klonowski W, Martín-Landrove M (2013) Fractals in the neurosciences, part II: clinical applications and future perspectives. Neuroscientist 21(1):30–43. https://doi.org/10.1177/1073858413513928
Smitha KA, Gupta AK, Jayasree RS (2015) Fractal analysis: fractal dimension and lacunarity from MR images for differentiating the grades of glioma. Phys Med Biol 60(17):6937–6947. https://doi.org/10.1088/0031-9155/60/17/6937
Lim JS (1990) Two-dimensional signal and image processing. Prentice-Hall, Inc.
Gonzalez RC, Woods RE, Eddins SL (2004) Digital image processing using MATLAB. Pearson Education
Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006. https://doi.org/10.1038/ncomms5006
van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H (2017) Computational Radiomics system to decode the radiographic phenotype. Cancer Res 77(21):e104–e107. https://doi.org/10.1158/0008-5472.Can-17-0339
Rizzo S, Botta F, Raimondi S, Origgi D, Fanciullo C, Morganti AG, Bellomi M (2018) Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp 2(1):36–36. https://doi.org/10.1186/s41747-018-0068-z
Earnest F, Kelly PJ, Scheithauer BW, Kall BA, Cascino TL, Ehman RL, Forbes GS, Axley PL (1988) Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166(3):823–827. https://doi.org/10.1148/radiology.166.3.2829270
Zhou M, Scott J, Chaudhury B, Hall L, Goldgof D, Yeom KW, Iv M, Ou Y, Kalpathy-Cramer J, Napel S, Gillies R, Gevaert O, Gatenby R (2018) Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches. Am J Neuroradiol 39(2):208–216. https://doi.org/10.3174/ajnr.A5391
Gatenby RA, Grove O, Gillies RJ (2013) Quantitative imaging in cancer evolution and ecology. Radiology 269(1):8–15. https://doi.org/10.1148/radiol.13122697
Zhou M, Hall L, Goldgof D, Gillies R, Gatenby R (2013) Survival time prediction of patients with glioblastoma multiforme tumors using spatial distance measurement, vol 8670. SPIE Medical Imaging. SPIE
Cao Y, Tsien CI, Nagesh V, Junck L, Ten Haken R, Ross BD, Chenevert TL, Lawrence TS (2006) Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]. Int J Radiat Oncol Biol Phys 64(3):876–885. https://doi.org/10.1016/j.ijrobp.2005.09.001
Zhou M, Hall L, Goldgof D, Russo R, Balagurunathan Y, Gillies R, Gatenby R (2014) Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results. Transl Oncol 7(1):5–13. https://doi.org/10.1593/tlo.13730
Chang PD, Malone HR, Bowden SG, Chow DS, Gill BJA, Ung TH, Samanamud J, Englander ZK, Sonabend AM, Sheth SA, McKhann GM 2nd, Sisti MB, Schwartz LH, Lignelli A, Grinband J, Bruce JN, Canoll P (2017) A multiparametric model for mapping cellularity in glioblastoma using radiographically localized biopsies. AJNR Am J Neuroradiol 38(5):890–898. https://doi.org/10.3174/ajnr.A5112
Gordillo N, Montseny E, Sobrevilla P (2013) State of the art survey on MRI brain tumor segmentation. Magn Reson Imaging 31(8):1426–1438. https://doi.org/10.1016/j.mri.2013.05.002
Gibbs P, Buckley DL, Blackband SJ, Horsman A (1996) Tumour volume determination from MR images by morphological segmentation. Phys Med Biol 41(11):2437–2446. https://doi.org/10.1088/0031-9155/41/11/014
Hojjatoleslami SA, Kittler J (1998) Region growing: a new approach. IEEE Trans Image Process 7(7):1079–1084. https://doi.org/10.1109/83.701170
Mie S, Lakare S, Ming W, Kaufman A, Nakajima M (2000) A gradient magnitude based region growing algorithm for accurate segmentation. In: Proceedings 2000 International Conference on Image Processing (Cat. No.00CH37101), 10–13 Sept. 2000. vol.443, pp 448–451. https://doi.org/10.1109/ICIP.2000.899432
Dam E, Loog M, Letteboer M (2004) Integrating automatic and interactive brain tumor segmentation. In: Proceedings of the 17th International Conference on Pattern Recognition, 2004. ICPR 2004., 26–26 Aug. 2004. vol 793, pp 790–793. https://doi.org/10.1109/ICPR.2004.1334647
Kannan SR (2008) A new segmentation system for brain MR images based on fuzzy techniques. Appl Soft Comput 8(4):1599–1606. https://doi.org/10.1016/j.asoc.2007.10.025
Iftekharuddin KM, Zheng J, Islam MA, Ogg RJ (2009) Fractal-based brain tumor detection in multimodal MRI. Appl Math Comput 207(1):23–41. https://doi.org/10.1016/j.amc.2007.10.063
Bernal J, Kushibar K, Asfaw DS, Valverde S, Oliver A, Martí R, Lladó X (2019) Deep convolutional neural networks for brain image analysis on magnetic resonance imaging: a review. Artif Intell Med 95:64–81. https://doi.org/10.1016/j.artmed.2018.08.008
Zikic D, Ioannou Y, Brown M, Criminisi A (2014) Segmentation of brain tumor tissues with convolutional neural networks. In: Proceedings MICCAI-BRATS. pp 36–39
Brébisson Ad, Montana G (2015) Deep neural networks for anatomical brain segmentation. In: 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), 7–12 June 2015. pp 20–28. https://doi.org/10.1109/CVPRW.2015.7301312
Havaei M, Davy A, Warde-Farley D, Biard A, Courville A, Bengio Y, Pal C, Jodoin P-M, Larochelle H (2017) Brain tumor segmentation with deep neural networks. Med Image Anal 35:18–31. https://doi.org/10.1016/j.media.2016.05.004
Zhang W, Li R, Deng H, Wang L, Lin W, Ji S, Shen D (2015) Deep convolutional neural networks for multi-modality isointense infant brain image segmentation. NeuroImage 108:214–224. https://doi.org/10.1016/j.neuroimage.2014.12.061
Lyksborg M, Puonti O, Agn M, Larsen R (2015) An ensemble of 2D convolutional neural networks for tumor segmentation. In: Paulsen RR, Pedersen KS (eds) Image Analysis, Cham, 2015. Springer International Publishing, p 201–211
Li W, Wang G, Fidon L, Ourselin S, Cardoso MJ, Vercauteren T (2017) On the compactness, efficiency, and representation of 3D convolutional networks: brain parcellation as a pretext task. In: Niethammer M, Styner M, Aylward S, et al (eds) Information Processing in Medical Imaging, Cham, 2017. Springer International Publishing, p 348–360
Kamnitsas K, Ledig C, Newcombe VFJ, Simpson JP, Kane AD, Menon DK, Rueckert D, Glocker B (2017) Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation. Med Image Anal 36:61–78. https://doi.org/10.1016/j.media.2016.10.004
McInerney T, Terzopoulos D (1996) Deformable models in medical image analysis: a survey. Med Image Anal 1(2):91–108. https://doi.org/10.1016/S1361-8415(96)80007-7
Wu Y, Zhao Z, Wu W, Lin Y, Wang M (2019) Automatic glioma segmentation based on adaptive superpixel. BMC Med Imaging 19(1):73. https://doi.org/10.1186/s12880-019-0369-6
Madabhushi A, Udupa JK (2006) New methods of MR image intensity standardization via generalized scale. Med Phys 33(9):3426–3434. https://doi.org/10.1118/1.2335487
Di Ieva A, Matula C, Grizzi F, Grabner G, Trattnig S, Tschabitscher M (2012) Fractal analysis of the susceptibility weighted imaging patterns in malignant brain tumors during antiangiogenic treatment: technical report on four cases serially imaged by 7 T magnetic resonance during a period of four weeks. World Neurosurg 77(5-6):785.e711–785.e721. https://doi.org/10.1016/j.wneu.2011.09.006
Sottoriva A, Spiteri I, Piccirillo SGM, Touloumis A, Collins VP, Marioni JC, Curtis C, Watts C, Tavaré S (2013) Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A 110(10):4009–4014. https://doi.org/10.1073/pnas.1219747110
Georgiadis P, Cavouras D, Kalatzis I, Glotsos D, Athanasiadis E, Kostopoulos S, Sifaki K, Malamas M, Nikiforidis G, Solomou E (2009) Enhancing the discrimination accuracy between metastases, gliomas and meningiomas on brain MRI by volumetric textural features and ensemble pattern recognition methods. Magn Reson Imaging 27(1):120–130. https://doi.org/10.1016/j.mri.2008.05.017
Yang D, Rao G, Martinez J, Veeraraghavan A, Rao A (2015) Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma. Med Phys 42(11):6725–6735. https://doi.org/10.1118/1.4934373
Molina D, Perez-Beteta J, Luque B, Arregui E, Calvo M, Borras JM, Lopez C, Martino J, Velasquez C, Asenjo B, Benavides M, Herruzo I, Martinez-Gonzalez A, Perez-Romasanta L, Arana E, Perez-Garcia VM (2016) Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival. Br J Radiol 89(1064):20160242. https://doi.org/10.1259/bjr.20160242
Chang K, Zhang B, Guo X, Zong M, Rahman R, Sanchez D, Winder N, Reardon DA, Zhao B, Wen PY, Huang RY (2016) Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab. Neuro-Oncology 18(12):1680–1687. https://doi.org/10.1093/neuonc/now086
Sanghani P, Ang BT, King NKK, Ren H (2018) Overall survival prediction in glioblastoma multiforme patients from volumetric, shape and texture features using machine learning. Surg Oncol 27(4):709–714. https://doi.org/10.1016/j.suronc.2018.09.002
Lao J, Chen Y, Li Z-C, Li Q, Zhang J, Liu J, Zhai G (2017) A deep learning-based radiomics model for prediction of survival in glioblastoma multiforme. Sci Rep 7(1):10353. https://doi.org/10.1038/s41598-017-10649-8
Li Q, Bai H, Chen Y, Sun Q, Liu L, Zhou S, Wang G, Liang C, Li Z-C (2017) A fully-automatic multiparametric radiomics model: towards reproducible and prognostic imaging signature for prediction of overall survival in glioblastoma multiforme. Sci Rep 7(1):14331. https://doi.org/10.1038/s41598-017-14753-7
Prasanna P, Patel J, Partovi S, Madabhushi A, Tiwari P (2017) Radiomic features from the peritumoral brain parenchyma on treatment-naive multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: preliminary findings. Eur Radiol 27(10):4188–4197. https://doi.org/10.1007/s00330-016-4637-3
Bahrami N, Piccioni D, Karunamuni R, Chang YH, White N, Delfanti R, Seibert TM, Hattangadi-Gluth JA, Dale A, Farid N, McDonald CR (2018) Edge contrast of the FLAIR hyperintense region predicts survival in patients with high-grade gliomas following treatment with bevacizumab. AJNR Am J Neuroradiol 39(6):1017–1024. https://doi.org/10.3174/ajnr.A5620
Bisdas S, Shen HC, Thust S, Katsaros V, Stranjalis G, Boskos C, Brandner S, Zhang JG (2018) Texture analysis- and support vector machine-assisted diffusional kurtosis imaging may allow in vivo gliomas grading and IDH-mutation status prediction: a preliminary study Scientific Reports 8. https://doi.org/10.1038/s41598-018-24438-4
Bae S, Choi YS, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Lee SK (2018) Radiomic MRI phenotyping of glioblastoma: improving survival prediction. Radiology 289(3):797–806. https://doi.org/10.1148/radiol.2018180200
Bahrami N, Hartman SJ, Chang YH, Delfanti R, White NS, Karunamuni R, Seibert TM, Dale AM, Hattangadi-Gluth JA, Piccioni D, Farid N, McDonald CR (2018) Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics. J Neuro-Oncol 139(3):633–642. https://doi.org/10.1007/s11060-018-2908-3
Chaddad A, Sabri S, Niazi T, Abdulkarim B (2018) Prediction of survival with multi-scale radiomic analysis in glioblastoma patients. Med Biol Eng Comput 56(12):2287–2300. https://doi.org/10.1007/s11517-018-1858-4
Darbar A, Waqas M, Enam SF, Mahmood SD (2018) Use of preoperative apparent diffusion coefficients to predict brain tumor grade. Cureus 10(3):e2284. https://doi.org/10.7759/cureus.2284
Osman AFI (2019) A multi-parametric MRI-based radiomics signature and a practical ML model for stratifying glioblastoma patients based on survival toward precision oncology. Front Comput Neurosci 13:58. https://doi.org/10.3389/fncom.2019.00058
Petrujkic K, Milosevic N, Rajkovic N, Stanisavljevic D, Gavrilovic S, Dzelebdzic D, Ilic R, Di Ieva A, Maksimovic R (2019) Computational quantitative MR image features - a potential useful tool in differentiating glioblastoma from solitary brain metastasis. Eur J Radiol 119:108634. https://doi.org/10.1016/j.ejrad.2019.08.003
Yang Y, Yan LF, Zhang X, Nan HY, Hu YC, Han Y, Zhang J, Liu ZC, Sun YZ, Tian Q, Yu Y, Sun Q, Wang SY, Zhang X, Wang W, Cui GB (2019) Optimizing texture retrieving model for multimodal MR image-based support vector machine for classifying glioma. J Magn Reson Imaging 49(5):1263–1274. https://doi.org/10.1002/jmri.26524
Schoenegger K, Oberndorfer S, Wuschitz B, Struhal W, Hainfellner J, Prayer D, Heinzl H, Lahrmann H, Marosi C, Grisold W (2009) Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma? Eur J Neurol 16(7):874–878. https://doi.org/10.1111/j.1468-1331.2009.02613.x
Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon I, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95(2):190–198. https://doi.org/10.3171/jns.2001.95.2.0190
Skogen K, Schulz A, Dormagen JB, Ganeshan B, Helseth E, Server A (2016) Diagnostic performance of texture analysis on MRI in grading cerebral gliomas. Eur J Radiol 85(4):824–829. https://doi.org/10.1016/j.ejrad.2016.01.013
Macyszyn L, Akbari H, Pisapia JM, Da X, Attiah M, Pigrish V, Bi Y, Pal S, Davuluri RV, Roccograndi L, Dahmane N, Martinez-Lage M, Biros G, Wolf RL, Bilello M, O'Rourke DM, Davatzikos C (2016) Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. Neuro-Oncology 18(3):417–425. https://doi.org/10.1093/neuonc/nov127
Lahmiri S, Boukadoum M (2012) Automatic brain MR images diagnosis based on edge fractal dimension and spectral energy signature. Conf Proc IEEE Eng Med Biol Soc 2012:6243–6246. https://doi.org/10.1109/embc.2012.6347421
Lahmiri S, Boukadoum M, Di Ieva A (2014) Detrended fluctuation analysis of brain hemisphere magnetic resonnance images to detect cerebral arteriovenousmalformations. In: 2014 IEEE International Symposium on Circuits and Systems (ISCAS), 1–5 June 2014. pp 2409–2412 https://doi.org/10.1109/ISCAS.2014.6865658
Lahmiri S, Boukadoum M (2013) Automatic detection of Alzheimer disease in brain magnetic resonance images using fractal features. In: 2013 6th International IEEE/EMBS Conference on Neural Engineering (NER), 6–8 Nov. 2013. p 1505–1508. https://doi.org/10.1109/NER.2013.6696231
Di Ieva A (Ed.) (2016) The fractal geometry of the brain. Springer, New York
Iftekharuddin KM, Jia W, Marsh R (2003) Fractal analysis of tumor in brain MR images. Mach Vis Appl 13(5):352–362. https://doi.org/10.1007/s00138-002-0087-9
Zook JM, Iftekharuddin KM (2005) Statistical analysis of fractal-based brain tumor detection algorithms. Magn Reson Imaging 23(5):671–678. https://doi.org/10.1016/j.mri.2005.04.002
Di Ieva A, Göd S, Grabner G, Grizzi F, Sherif C, Matula C, Tschabitscher M, Trattnig S (2013) Three-dimensional susceptibility-weighted imaging at 7 T using fractal-based quantitative analysis to grade gliomas. Neuroradiology 55(1):35–40. https://doi.org/10.1007/s00234-012-1081-1
Kristin RS, Alvord EC, Murray JD (2003) Dynamics of a model for brain tumors reveals a small window for therapeutic intervention. Discrete Contin Dynam Syst B 4(1):289–295. https://doi.org/10.3934/dcdsb.2004.4.289
Sedivy R (1996) Fractal tumours: their real and virtual images. Wien Klin Wochenschr 108(17):547–551
Di Ieva A (2010) Angioarchitectural morphometrics of brain tumors: are there any potential histopathological biomarkers? Microvasc Res 80(3):522–533. https://doi.org/10.1016/j.mvr.2010.09.005
Di Ieva A, Grizzi F, Ceva-Grimaldi G, Russo C, Gaetani P, Aimar E, Levi D, Pisano P, Tancioni F, Nicola G, Tschabitscher M, Dioguardi N, Baena RRY (2007) Fractal dimension as a quantitator of the microvasculature of normal and adenomatous pituitary tissue. J Anat 211(5):673–680. https://doi.org/10.1111/j.1469-7580.2007.00804.x
Di Ieva A, Grizzi F, Gaetani P, Goglia U, Tschabitscher M, Mortini P, Rodriguez y Baena R (2008) Euclidean and fractal geometry of microvascular networks in normal and neoplastic pituitary tissue. Neurosurg Rev 31(3):271–281. https://doi.org/10.1007/s10143-008-01277
Di Ieva A, Grizzi F, Tschabitscher M, Colombo P, Casali M, Simonelli M, Widhalm G, Muzzio PC, Matula C, Chiti A, Rodriguez y Baena R (2010) Correlation of microvascular fractal dimension with positron emission tomography [(11)C]-methionine uptake in glioblastoma multiforme: preliminary findings. Microvasc Res 80(2):267–273. https://doi.org/10.1016/j.mvr.2010.04.003
Di Ieva A, Bruner E, Widhalm G, Minchev G, Tschabitscher M, Grizzi F (2012) Computer-assisted and fractal-based morphometric assessment of microvascularity in histological specimens of gliomas. Sci Rep 2(1):429. https://doi.org/10.1038/srep00429
Bates DW, Saria S, Ohno-Machado L, Shah A, Escobar G (2014) Big data in health care: using analytics to identify and manage high-risk and high-cost patients. Health Aff 33(7):1123–1131. https://doi.org/10.1377/hlthaff.2014.0041
Abrol S, Kotrotsou A, Salem A, Zinn PO, Colen RR (2017) Radiomic phenotyping in brain cancer to unravel hidden information in medical images. Top Magn Reson Imaging 26(1):43–53. https://doi.org/10.1097/rmr.0000000000000117
Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216):1061–1068. https://doi.org/10.1038/nature07385
Prior FW, Clark K, Commean P, Freymann J, Jaffe C, Kirby J, Moore S, Smith K, Tarbox L, Vendt B, Marquez G (2013) TCIA: an information resource to enable open science. Conf Proc IEEE Eng Med Biol Soc 2013:1282–1285. https://doi.org/10.1109/embc.2013.6609742
Kalpathy-Cramer J, Freymann JB, Kirby JS, Kinahan PE, Prior FW (2014) Quantitative imaging network: data sharing and competitive algorithmvalidation leveraging the cancer imaging archive. Transl Oncol 7(1):147–152. https://doi.org/10.1593/tlo.13862
Heilbrun ME (2013) Evaluating RadLex and real world radiology reporting: are we there yet? Acad Radiol 20(11):1327–1328. https://doi.org/10.1016/j.acra.2013.09.011
Tibshirani R (1996) Regression shrinkage and selection via the lasso. J R Stat Soc Ser B Methodol 58(1):267–288
Gevaert O, Xu J, Hoang CD, Leung AN, Xu Y, Quon A, Rubin DL, Napel S, Plevritis SK (2012) Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. Radiology 264(2):387–396. https://doi.org/10.1148/radiol.12111607
Shen W, Zhou M, Yang F, Dong D, Yang C, Zang Y, Tian J (2016) Learning from experts: developing transferable deep features for patient-level lung cancer prediction. In: Ourselin S, Joskowicz L, Sabuncu MR, Unal G, Wells W (eds) Medical Image Computing and Computer-Assisted Intervention – MICCAI 2016, Cham, 2016. Springer International Publishing, p 124–131
Mamoshina P, Vieira A, Putin E, Zhavoronkov A (2016) Applications of deep learning in biomedicine. Mol Pharm 13(5):1445–1454. https://doi.org/10.1021/acs.molpharmaceut.5b00982
Chu HH, Choi SH, Ryoo I, Kim SC, Yeom JA, Shin H, Jung SC, Lee AL, Yoon TJ, Kim TM, Lee S-H, Park C-K, Kim J-H, Sohn C-H, Park S-H, Kim IH (2013) Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging. Radiology 269(3):831–840. https://doi.org/10.1148/radiol.13122024
Chang PD, Chow DS, Yang PH, Filippi CG, Lignelli A (2017) Predicting glioblastoma recurrence by early changes in the apparent diffusion coefficient value and signal intensity on FLAIR images. AJR Am J Roentgenol 208(1):57–65. https://doi.org/10.2214/ajr.16.16234
Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Mischel PS, Pope WB (2011) Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro-Oncology 13(4):401–409. https://doi.org/10.1093/neuonc/noq206
Zhou M, Hall LO, Goldgof DB, Russo R, Gillies RJ, Gatenby RA (2015) Decoding brain cancer dynamics: a quantitative histogram-based approach using temporal MRI. In: Progress in Biomedical Optics and Imaging - Proceedings of SPIE. https://doi.org/10.1117/12.2075545
Hygino da Cruz LC, Rodriguez I, Domingues RC, Gasparetto EL, Sorensen AG (2011) Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. Am J Neuroradiol 32(11):1978–1985. https://doi.org/10.3174/ajnr.A2397
Wardlaw G, Wong R, Noseworthy MD (2008) Identification of intratumour low frequency microvascular components via BOLD signal fractal dimension mapping. Phys Med 24(2):87–91. https://doi.org/10.1016/j.ejmp.2008.01.006
Michallek F, Dewey M (2014) Fractal analysis in radiological and nuclear medicine perfusion imaging: a systematic review. Eur Radiol 24(1):60–69. https://doi.org/10.1007/s00330-013-2977-9
Acknowledgments
Professor Antonio Di Ieva received the 2019 John Mitchell Crouch Fellowship from the Royal Australasian College of Surgeons (RACS) which, along with Macquarie University co-funding, supported the opening of the Computational NeuroSurgery (CNS) Lab at Macquarie University, Sydney, Australia. Moreover, he is supported by an Australian Research Council (ARC) Future Fellowship (2019-2023, FT190100623). KJ would like to personally thank Professor Antonio Di Ieva, Dr. Carlo Russo, and Dr. Abhishta Bhandari for their untiring support during the course of this work. We also thank Dr. Bhandari for contributing to the figure used in this manuscript.
Funding
No funding was received for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jang, K., Russo, C. & Di Ieva, A. Radiomics in gliomas: clinical implications of computational modeling and fractal-based analysis. Neuroradiology 62, 771–790 (2020). https://doi.org/10.1007/s00234-020-02403-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-020-02403-1